scholarly article | Q13442814 |
P356 | DOI | 10.1001/ARCHNEUR.57.3.347 |
P698 | PubMed publication ID | 10714660 |
P50 | author | Jody Corey-Bloom | Q50848575 |
Leon J. Thal | Q56839882 | ||
P2093 | author name string | Hansen LA | |
Tiraboschi P | |||
Hohl U | |||
P433 | issue | 3 | |
P921 | main subject | dementia | Q83030 |
P304 | page(s) | 347-351 | |
P577 | publication date | 2000-03-01 | |
P1433 | published in | Archives of Neurology | Q15766672 |
P1476 | title | Diagnostic accuracy of dementia with Lewy bodies | |
P478 | volume | 57 |
Q39615532 | (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A compa |
Q45982741 | A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease. |
Q49070070 | CASE REPORT: Psychotic symptoms complicate the clinical differentiation of Parkinson's disease with major depressive disorder from dementia with Lewy bodies |
Q47344957 | Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically? |
Q35113689 | Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians |
Q90377168 | Common age-related neuropathologies and yearly variability in cognition |
Q36315947 | Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies. |
Q74089880 | Definition of 'neuroleptic sensitivity' |
Q57306397 | Dementia with Lewy bodies |
Q80690619 | Dementia with Lewy bodies |
Q35474145 | Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older |
Q35029466 | Dementia with Lewy bodies: clinical characteristics and diagnostic criteria. |
Q35029472 | Dementia with Lewy bodies: neuropathology |
Q48469027 | EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study. |
Q46001712 | Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease. |
Q35553096 | Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia |
Q30533941 | Extrapyramidal signs by dementia severity in Alzheimer disease and dementia with Lewy bodies |
Q48587961 | Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease |
Q48264359 | Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP. |
Q47977064 | Hypochondriasis as an early manifestation of dementia with Lewy bodies: an autopsied case report |
Q34566561 | Lewy bodies and dementia |
Q48263978 | Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem |
Q40795880 | Limbic lobe microvacuolation is minimal in Alzheimer's disease in the absence of concurrent Lewy body disease |
Q38901561 | Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort |
Q37954450 | Modeling the dementia epidemic. |
Q30756562 | Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology |
Q74245351 | Neuropathological correlates to clinically defined dementia with Lewy bodies |
Q33637285 | PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders |
Q48378397 | Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease |
Q34138207 | The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease |
Q22250951 | The differential diagnosis of Parkinson's disease |
Q35136912 | The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease |
Q26853347 | The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease |
Q43164212 | The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies. |
Q34114062 | Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe |
Q37139055 | Visual search in Dementia with Lewy Bodies and Alzheimer's disease |
Q80027950 | [Hallucinations and dementia. Prevalence, clinical presentation and pathophysiology] |